GRI Bio, Inc.
GRI · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $6,333 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $1 | $1 | – |
| Gross Profit | -$1 | -$1 | -$1 | – |
| % Margin | -0% | – | – | – |
| R&D Expenses | $1,769 | $1,879 | $1,640 | – |
| G&A Expenses | $1,596 | $0 | $0 | – |
| SG&A Expenses | $1,595 | $1,017 | $1,410 | – |
| Sales & Mktg Exp. | $0 | $0 | $0 | – |
| Other Operating Expenses | $0 | $0 | $0 | – |
| Operating Expenses | $3,364 | $2,896 | $3,050 | – |
| Operating Income | -$3,365 | -$2,897 | -$3,051 | – |
| % Margin | -53.1% | – | – | – |
| Other Income/Exp. Net | $6 | $5 | $5 | – |
| Pre-Tax Income | -$3,359 | -$2,892 | -$3,046 | – |
| Tax Expense | $0 | $0 | $0 | – |
| Net Income | -$3,359 | -$2,892 | -$3,046 | – |
| % Margin | -53% | – | – | – |
| EPS | -1.28 | -1.31 | -5.8 | – |
| % Growth | 2.3% | 77.4% | – | – |
| EPS Diluted | -1.28 | -1.31 | -5.8 | – |
| Weighted Avg Shares Out | 2,621 | 2,205 | 525 | – |
| Weighted Avg Shares Out Dil | 2,621 | 2,205 | 525 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $5 | $5 | – |
| Interest Expense | $0 | $0 | $0 | – |
| Depreciation & Amortization | $1 | $1 | $1 | – |
| EBITDA | -$3,358 | -$2,891 | -$3,045 | – |
| % Margin | -53% | – | – | – |